• Profile
Close
Sign Up / Log In
Dr. Kumar Prabhash

editor_pick-icon Originals

Oralcancer 1571312708 1582897550
Deriving the most effective metronomic dose of methotrexate for advanced oral cancer: Dr. Kumar Prabhash
Triple oral metronomic chemotherapy with e... more»Triple oral metronomic chemotherapy with erlotinib, methotrexate, and celecoxib is efficacious in platinum-refractory oral cavity cancers and represents a new therapeutic option in patients with poor prognosis. «less
Oct 18, 2019
Read More
Share

editor_pick-icon Originals

Dr kp article 1566210686 1582897677
Dr Kumar Prabhash's commentary: Gefitinib vs. Gefitinib plus Pemetrexed and Carboplatin chemotherapy in EGFR-Mutated lung cancer
A clinical study by Dr. Kumar Prabhash and... more»A clinical study by Dr. Kumar Prabhash and his team was published in JCO in the month of August 2019 which concluded that adding pemetrexed and carboplatin chemotherapy to gefitinib significantly prolonged PFS and OS but increased toxicity in patients with NSCLC. «less
Aug 20, 2019
Read More
Share
Back to top
x
M3 app logo
Choose easy access to M3 India from your mobile!

Add to home

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay